文献速递眼底病与葡萄膜炎

继发于年龄相关性黄斑变性的地图状萎缩自然史:Proxima A与B前瞻性临床试验结果

Natural History of Geographic Atrophy Secondary to Age-Related Macular Degeneration: Results from the Prospective Proxima A and B Clinical Trials.
PubMed 文献 · Ophthalmology · 2019-12-14

Proxima A和B为全球前瞻性非干预观察性临床试验,纳入年龄≥50岁的地图状萎缩(GA)患者。24个月时GA病灶面积和视功能均显著恶化,基线非中心凹下GA病灶进展更快,且低亮度视力缺损越大进展倾向越明显。

要点

  • 24个月时双眼GA患者GA面积调整均值增加3.87 mm²,单眼GA合并对侧CNV者增加3.55 mm²。
  • 研究眼BCVA在24个月时下降9.49至13.88个ETDRS字母,低亮度视力下降7.57至8.37个字母。
  • 基线非中心凹下GA病灶比中心凹下病灶进展更快。

核心结论

  • Proxima A和B研究强调GA在2年内对视功能造成严重影响且病灶进展迅速,包括基线为单眼GA的患者。

研究设计与样本

  • Proxima A和Proxima B为全球、前瞻性、非干预、观察性临床试验。
  • Proxima A纳入双眼GA且无脉络膜新生血管(CNV)的患者295例,年龄≥50岁。
  • Proxima B纳入研究眼GA无CNV且对侧眼CNV±GA者168例,或对侧眼无CNV/GA者32例。

主要发现

  • 24个月时GA病灶面积较基线的调整均值(标准误)变化:双眼GA组3.87(0.15)mm²,对侧眼CNV组3.55(0.16)mm²,对侧眼中度AMD组2.96(0.25)mm²。
  • 基线非中心凹下GA病灶较中心凹下病灶进展更快,且所有患者中GA进展随基线低亮度视力缺损增大而倾向增加。
  • Proxima B中度AMD队列12个月时对侧眼转化为GA或CNV的比例分别为30%和6.7%。
  • 研究眼BCVA从基线至24个月的调整均值(标准误)变化:Proxima A为-13.88(1.40)个ETDRS字母,对侧眼CNV组为-9.49(1.29)个字母,对侧眼中度AMD组为-11.48(3.39)个字母。
  • 研究眼低亮度视力从基线至24个月的调整均值(标准误)变化:Proxima A为-7.64(1.20)个ETDRS字母,对侧眼CNV组为-7.57(1.26)个字母,对侧眼中度AMD组为-8.37(3.02)个字母。

临床怎么用

  • 对GA患者应关注2年内病灶面积和视功能的快速进展,尤其是基线非中心凹下病灶及低亮度视力缺损较大者。
  • 对单眼GA患者需监测对侧眼转化为GA或CNV的风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To better characterize visual function decline and geographic atrophy (GA) progression secondary to age-related macular degeneration (AMD). DESIGN: Proxima A (NCT02479386)/Proxima B (NCT02399072) were global, prospective, noninterventional, observational clinical trials. PARTICIPANTS: Eligible patients were aged ≥50 years. Patients in Proxima A had bilateral GA without choroidal neovascularization (CNV) in either eye (N = 295). Patients in Proxima B had GA without CNV in the study eye and CNV±GA in the fellow eye (fellow eye CNV cohort, n = 168) or GA without CNV in the study eye, no CNV/GA in the fellow eye (fellow eye intermediate AMD cohort, n = 32). METHODS: Changes in visual function and imaging/anatomic parameters were evaluated over time using a mixed model for repeated measurement accounting for key baseline characteristics. MAIN OUTCOME MEASURES: Prespecified end points included change in GA area from baseline, best-corrected visual acuity (BCVA) score assessed by Early Treatment Diabetic Retinopathy Study (ETDRS), and visual acuity under low-luminance (LLVA). RESULTS: At 24 months, adjusted mean (standard error) change in GA lesion area from baseline was 3.87 (0.15) mm2 in participants with bilateral GA (Proxima A), 3.55 (0.16) mm2 in the fellow eye CNV cohort (Proxima B), and 2.96 (0.25) mm2 in the fellow eye intermediate AMD cohort (Proxima B). Progression of GA was greater in patients with baseline nonsubfoveal (vs. subfoveal) GA lesions and tended to increase as baseline low-luminance deficit increased (all patients). Conversion to GA or CNV in the fellow eye occurred in 30% and 6.7% of participants, respectively, in the Proxima B intermediate AMD cohort at month 12. Adjusted mean (standard error) changes in BCVA and LLVA (ETDRS letters) in the study eye from baseline to 24 months were -13.88 (1.40) and -7.64 (1.20) in Proxima A, -9.49 (1.29) and -7.57 (1.26) in Proxima B fellow eye CNV cohort, and -11.48 (3.39) and -8.37 (3.02) in Proxima B fellow eye intermediate AMD cohort, respectively. CONCLUSIONS: The prospective Proxima A and B studies highlight the severe functional impact of GA and the rapid rate of GA lesion progression over a 2-year period, including in patients with unilateral GA at baseline.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Holekamp N, Wykoff CC, Schmitz-Valckenberg S, et al. Natural History of Geographic Atrophy Secondary to Age-Related Macular Degeneration: Results from the Prospective Proxima A and B Clinical Trials. Ophthalmology. 2019. PMID: 32081489. doi:10.1016/j.ophtha.2019.12.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。